Detalhe da pesquisa
1.
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
N Engl J Med
; 387(21): 1923-1934, 2022 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36342113
2.
Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials.
Lancet
; 401(10384): 1293-1301, 2023 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36893777
3.
Inflammation drives residual risk in chronic kidney disease: a CANTOS substudy.
Eur Heart J
; 43(46): 4832-4844, 2022 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35943897
4.
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.
N Engl J Med
; 380(8): 752-762, 2019 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30415610
5.
The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials.
Eur Heart J
; 42(9): 896-903, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33417682
6.
Adverse effects related to methotrexate polyglutamate levels: adjudicated results from the cardiovascular inflammation reduction trial.
Rheumatology (Oxford)
; 60(6): 2963-2968, 2021 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34144603
7.
Effects of Interleukin-1ß Inhibition on Incident Anemia: Exploratory Analyses From a Randomized Trial.
Ann Intern Med
; 172(8): 523-532, 2020 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32203978
8.
Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1ß inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis.
Eur Heart J
; 41(23): 2153-2163, 2020 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31504417
9.
Comparison of interleukin-6, C-reactive protein, and low-density lipoprotein cholesterol as biomarkers of residual risk in contemporary practice: secondary analyses from the Cardiovascular Inflammation Reduction Trial.
Eur Heart J
; 41(31): 2952-2961, 2020 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32221587
10.
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
N Engl J Med
; 377(12): 1119-1131, 2017 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28845751
11.
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial.
Lancet
; 391(10118): 319-328, 2018 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29146124
12.
Relationship of Interleukin-1ß Blockade With Incident Gout and Serum Uric Acid Levels: Exploratory Analysis of a Randomized Controlled Trial.
Ann Intern Med
; 169(8): 535-542, 2018 10 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30242335
13.
Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS).
Eur Heart J
; 39(38): 3499-3507, 2018 10 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30165610
14.
Effect of interleukin-1ß inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial.
Lancet
; 390(10105): 1833-1842, 2017 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28855077
15.
The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials.
Eur Heart J
; 36(24): 1536-46, 2015 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25802390
16.
Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial.
Lancet
; 380(9841): 565-71, 2012 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-22883507
17.
Lack of association between SLCO1B1 polymorphisms and clinical myalgia following rosuvastatin therapy.
Am Heart J
; 165(6): 1008-14, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23708174
18.
Canakinumab's Effect Against Subsequent Gout Flares and High-Sensitivity C-Reactive Protein Levels: A Causal Mediation Analysis.
Arthritis Care Res (Hoboken)
; 75(4): 817-824, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34874116
19.
A randomized trial of rosuvastatin in the prevention of venous thromboembolism.
N Engl J Med
; 360(18): 1851-61, 2009 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-19329822
20.
Relationship of lipoprotein-associated phospholipase A2 mass and activity with incident vascular events among primary prevention patients allocated to placebo or to statin therapy: an analysis from the JUPITER trial.
Clin Chem
; 58(5): 877-86, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22419750